Karuna Therapeutics Inc. (KRTX) Tops Q4 EPS by 15c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. CVS
9. SPY
10. XYZ

Go back to Karuna Therapeutics Inc. (KRTX) Tops Q4 EPS by 15c

Karuna Therapeutics Reports Fourth Quarter and Year End 2019 Financial Results and Provides General Business Update

March 24, 2020 6:00 AM EDT

Met primary endpoint in Phase 2 clinical trial of KarXT for the treatment of acute psychosis in patients with schizophrenia and demonstrated favorable safety profile with no significant weight gain, somnolence or extrapyramidal side effects relative to placebo Met secondary endpoints on both PANSS positive and negative symptom subscales, PANSS Marder factor and CGI-S Raised more than $430 million in gross proceeds during 2019, funding operations for at least the next three years Initiated a... More